期刊
NEUROBIOLOGY OF AGING
卷 49, 期 -, 页码 86-99出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2016.09.007
关键词
Aging; Alzheimer's disease; Brain; Brain-derived neurotrophic factor; Dog; Canine; Cerebrovascular; Immunotherapy
资金
- National Institutes of Health, National Institute on Aging [R01AG032550]
- National Center for Advancing Translational Sciences [UL1TR000117]
Beta-amyloid (A beta) immunotherapy is a promising intervention to slow Alzheimer's disease. Aging dogs naturally accumulate A beta and show cognitive decline. An active vaccine against fibrillar A beta 1-42 (VAC) in aged beagles resulted in maintenance but not improvement of cognition along with reduced brain A beta. Behavioral enrichment (ENR) led to cognitive benefits but no reduction in A beta. We hypothesized cognitive outcomes could be improved by combining VAC with ENR in aged dogs. Aged dogs (11-12 years) were placed into 4 groups: (1) control/control (C/C); (2) control/VAC (C/V); (3) ENR/control (E/C); and (4) ENR/VAC (E/V) and treated for 20 months. VAC decreased brain A beta, pyroglutamate A beta, increased cerebrospinal fluid Ab 42 and brain-derived neurotrophic factor RNA levels but also increased microhemorrhages. ENR reduced brain A beta and prevented microhemorrhages. The combination treatment resulted in a significant maintenance of learning over time, reduced A beta, and increased brain-derived neurotrophic factor mRNA despite increased microhemorrhages; however, there were no benefits to memory. These results suggest that the combination of immunotherapy with behavioral enrichment leads to cognitive maintenance associated with reduced neuropathology that may benefit people with Alzheimer's disease. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据